Roche's Itovebi gains FDA approval for breast cancer, challenging Novartis and AstraZeneca with potential $2.3 billion sales.

Procept BioRobotics' WATER IV PCa trial compares Aquablation to radical prostatectomy in treating localized prostate cancer, ...

Dechra is hosting an exclusive series of CPD sessions at the London Vet Show (LVS) on Thursday 14 and Friday 15 November ...

Siemens unveils Capital X, a cloud-based software suite transforming electrical and electronic systems engineering with ...

Abbott is making significant strides in the diabetes technology sector, with CEO Robert Ford highlighting the potential of continuous glucose monitors (CGMs) to reach a wider market. This growth is ...

A recent report highlights a significant inclination among NHS dental patients to consider private care, with six out of ten ...

Medtronic, a leading player in medical technology, is evaluating its Affera mapping and ablation system featuring the Sphere-9 catheter for treating ventricular tachycardia (VT). This heart rhythm ...

Commenting on the publication today of the NHS monthly performance statistics, Tim Gardner, Assistant Director of Policy at ...

The FDA’s recent approval of Imuldosa, developed by Accord BioPharma as a biosimilar to Stelara, marks an expansion in treatments for chronic inflammatory conditions. This approval, encompassing ...

Ovation Agriculture, emerging from Scotland’s Rural College, is set to revolutionise cattle health with its new dental gag. This innovative tool, designed to facilitate thorough examination of cows’ ...

BioAffinity Technologies’ (Nasdaq: BIAF) Vice President of Diagnostics, Jennifer Rebeles, Ph.D., was part of a panel of worldwide experts that published the peer-reviewed paper, “Implementation of ...

Abbott, a global leader in healthcare innovation, has received FDA clearance for its advanced cardiac mapping technology. This clearance is a big step in its ongoing clinical studies of pulsed field ...